
Opinion|Videos|December 14, 2023
Introduction to Bispecific Antibodies: Operationalizing Administration and Follow-Up
Author(s)Justin LaPorte, PharmD, BCOP
Justin LaPorte, PharmD, BCOP, introduces the purpose and objectives for the program.
Advertisement
Episodes in this series

Now Playing
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
FDA Grants FTD to GPRC5D Bispecific LBL-034 for R/R Multiple Myeloma
4
Multiomic Real-World Data Predict Outcomes in Metastatic Breast Cancer
5

















